Applying a Pareto-Based Efficiency Frontier to Inform Value-Based Pricing for Gaucher Disease Therapies in Brazil

• by Marcus Carvalho Borin, Ludmila Peres Gargano, Francisco de Assis Acurcio, Juliana Álvares-Teodoro, Augusto Afonso Guerra

• October 9, 2026

Rapid WGS Improves Pediatric Diagnosis

Three-day whole-genome sequencing led to more personalized care for children newly diagnosed with cancer

• October 15, 2026

• 3 min

Real World Adoption and Associated Outcomes of Aspirin Avoidance After HeartMate 3 Implantation: The PRAISE HM3 Study

• by Farooq H. Sheikh, Ezequiel J. Molina, Ulrich P. Jorde, Mirnela P. Byku, Jeeyun A. Kim, Deepti Bettampadi, Finn Gustafsson, Mandeep R. Mehra

• October 12, 2026

No evidence of hypercoagulability, altered fibrinolysis, or increased fibrin(ogen) microaggregates in never-hospitalized long COVID

• by Emily Fraser, Kher Ng, Neda Hasan, Isobel Dunstan, Avianna Laws, Fraser Macrae, Jeries Abu-Hanna, Robert Ariens, Victoria Harris, Jason Oke, Laura Saunders, James Grist, Guilhem Collier, Paul Hughes, Jim Wild, Roger Thompson, Fergus Gleeson, Susan Shapiro

• October 19, 2026